MedTrace Logo

Effects of Dance on the Turning Characteristics of Patients With Parkinson's Disease

NCT05113524 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2022-05-25

No results posted yet for this study

Summary

The proposed control intervention trial, aims to analyse the effects of Dance in the turning characteristics in patients with Parkinson Disease (PD) using three- dimensional (3D) analysis during the timed up and go (TUG) test.

Conditions

  • Parkinson Disease(PD)

Interventions

OTHER

Dance

The dance program consists of 3 months of dance classes. Classes are specifically designed for people with Parkisnon's and lead by a qualified dance instructor experienced in teaching this population. The in-person dance classes are conducted in an appropriate room with chairs and ballet barres once a week. In addition, the participants received a CD containing a video of the recorded dance routine to be performed at home once a week. The class typically included a warm-up (10-15 min.), barre ballet exercises (10-15 min.), general dance-related activities (15-20 min), and a cool-down (10-15 min).

OTHER

No intervention

Controls, not alter their personal lifestyle, but will undergo the same testing as the exercise intervention group.

Sponsors & Collaborators

  • University of Wolverhampton

    collaborator OTHER

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

    collaborator OTHER_GOV

  • Federal University of Rio Grande do Sul

    lead OTHER

Principal Investigators

  • Aline Nogueira Haas, PhD · Federal University of Rio Grande do Sul

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-10
Primary Completion
2019-05-01
Completion
2020-06-30

Countries

  • Brazil
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05113524 on ClinicalTrials.gov